Patients relax in a comfortable recliner or bed during the infusion, and most resume daily activities right after
This includes developing bifunctional molecules (e.g., Fer-1 conjugated to Nec-1, a necroptosis inhibitor) that co-target complementary pathways or epigenetic editing tools (e.g., dCas9-SunTag-KRAB systems) to dynamically suppress the transcription of ferroptosisnecroptosis crosstalk nodes (e.g., RIPK3)
Different groups were treated with GSH, without GSH, or with different concentrations of GSH
Despite widespread adoption, these agents are not approved by the U.S
The primary endpoint was HbA1c change from baseline to 24 weeks, and secondary endpoints included change in HbA1c and bodyweight at 36 weeks
The animal study protocol was approved by the Institutional Review Board of Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine (protocol code AEWC-2024364)